Founded in 2008, Gubra is a privately-held biotech company with two primary areas of business: pre-clinical contract research (CRO) services and proprietary early target and drug discovery programs.

Gubra’s focus is the metabolic space (obesity, diabetes, NASH and gastrointestinal diseases), where they specialize in in vivo pharmacology, peptide chemistry, molecular pharmacology, histology, stereology, NGS (next generation sequencing), bioinformatics and ex vivo assays.

Contact name:

Henrik Blou


Hørsholm Kongevej 11B, 2970 Hørsholm, Denmark

If you cannot find what you are looking for or if you have feedback to our website, please do not hesitate to contact or +45 5150 0560

Copyright 2010 Danskbiotek. All rights reserved.